Axitinib

Axitinib is a targeted cancer medication used primarily to treat advanced kidney cancer. It works by blocking specific proteins called receptors involved in blood vessel growth within tumors. Tumors need new blood vessels to get nutrients and grow, and axitinib helps prevent this process, effectively starving the cancer cells. By inhibiting these receptors, axitinib can slow or stop tumor growth, improving outcomes for patients with this type of cancer. It is usually taken orally as a pill and is managed carefully by healthcare providers due to potential side effects.